Galapagos NV
GLPG
#4563
Rank
A$3.17 B
Marketcap
A$47.56
Share price
-0.57%
Change (1 day)
13.82%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: A$3.17 Billion

As of December 2025 Galapagos NV has a market cap of A$3.17 Billion. This makes Galapagos NV the world's 4563th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025A$3.17 B9.94%
2024A$2.89 B-26.44%
2023A$3.93 B-8.43%
2022A$4.29 B-14.79%
2021A$5.03 B-40.16%
2020A$8.42 B-56.36%
2019A$19.29 B170.83%
2018A$7.12 B15.82%
2017A$6.15 B48.8%
2016A$4.13 B22.17%
2015A$3.38 B385.23%
2014A$0.69 B-0.75%
2013A$0.70 B29.21%
2012A$0.54 B56.33%
2011A$0.34 B-16.94%
2010A$0.41 B47.6%
2009A$0.28 B94.81%
2008A$0.14 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Galapagos NV was reported to be:

A$3.13 Billion
by Nasdaq info icon info icon
A$3.17 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
A$420.95 B 13,138.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
A$732.43 B 22,934.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$182.01 B 5,624.04%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
A$601.55 B 18,817.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
A$0.13 B-95.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$327.74 B 10,206.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$49.15 B 1,445.91%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
A$147.11 B 4,526.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$374.98 B 11,692.81%๐Ÿ‡บ๐Ÿ‡ธ USA